IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $36.00

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by Royal Bank of Canada from $32.00 to $36.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also commented on the stock. SVB Leerink assumed coverage on shares […]

Leave a Reply

Your email address will not be published.

Previous post Raymond James Downgrades Black Stone Minerals (NYSE:BSM) to Market Perform
Next post Colombia September 2023: Mazda (+31.3%), Nissan (+30.6%) challenge market down -34.7%